Maribel Teixeira

Development and characterization of PLGA nanoparticles containing 1,3-dihydroxy-2-methylxanthone with improved antitumor activity on a human breast cancer cell line

M. Pedro, M. Pinto, M. Teixeira, 2019, Pharmaceutical development and technology.

Steric stabilization of nanoparticles: Size and surface properties

S. Simões, R. Gaspar, C. Lourenco, 1996 .

Improvement of the inhibitory effect of xanthones on NO production by encapsulation in PLGA nanocapsules

M. Pinto, M. Teixeira, F. Cerqueira, 2005, Journal of drug targeting.

Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone.

M. Alonso, M. Pinto, M. Teixeira, 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Development of Liposomes-in-Hydrogel Formulations Containing Betamethasone for Topical Therapy

M. Tiritan, V. Gonçalves, Raquel Silva, 2018 .

Development and validation of an HPLC method for the quantitation of 1,3-dihydroxy-2-methylxanthone in biodegradable nanoparticles.

M. Pinto, C. M. Barbosa, C. Afonso, 2008, Journal of chromatographic science.